PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) FCF Margin % : 0.00% (As of . 20)

View and export this data going back to 2021. Start your Free Trial

What is PT Diagnos Laboratorium Utama Tbk FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. PT Diagnos Laboratorium Utama Tbk's Free Cash Flow for the six months ended in . 20 was Rp0.00 Mil. PT Diagnos Laboratorium Utama Tbk's Revenue for the six months ended in . 20 was Rp0.00 Mil. Therefore, PT Diagnos Laboratorium Utama Tbk's FCF Margin % for the quarter that ended in . 20 was 0.00%.

As of today, PT Diagnos Laboratorium Utama Tbk's current FCF Yield % is 0.00%.

The historical rank and industry rank for PT Diagnos Laboratorium Utama Tbk's FCF Margin % or its related term are showing as below:

ISX:DGNS's FCF Margin % is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: -5.655
* Ranked among companies with meaningful FCF Margin % only.

PT Diagnos Laboratorium Utama Tbk FCF Margin % Historical Data

The historical data trend for PT Diagnos Laboratorium Utama Tbk's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Diagnos Laboratorium Utama Tbk FCF Margin % Chart

PT Diagnos Laboratorium Utama Tbk Annual Data

Trend

FCF Margin %

PT Diagnos Laboratorium Utama Tbk Semi-Annual Data

FCF Margin %

Competitive Comparison of PT Diagnos Laboratorium Utama Tbk's FCF Margin %

For the Diagnostics & Research subindustry, PT Diagnos Laboratorium Utama Tbk's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Diagnos Laboratorium Utama Tbk's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, PT Diagnos Laboratorium Utama Tbk's FCF Margin % distribution charts can be found below:

* The bar in red indicates where PT Diagnos Laboratorium Utama Tbk's FCF Margin % falls into.

PT Diagnos Laboratorium Utama Tbk FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

PT Diagnos Laboratorium Utama Tbk's FCF Margin for the fiscal year that ended in . 20 is calculated as

FCF Margin	=	Free Cash Flow (A: . 20 )	/	Revenue (A: . 20 )
	=		/
	=	%

PT Diagnos Laboratorium Utama Tbk's FCF Margin for the quarter that ended in . 20 is calculated as

FCF Margin	=	Free Cash Flow (Q: . 20 )	/	Revenue (Q: . 20 )
	=		/
	=	%

PT Diagnos Laboratorium Utama Tbk FCF Margin % Related Terms

Thank you for viewing the detailed overview of PT Diagnos Laboratorium Utama Tbk's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Diagnos Laboratorium Utama Tbk Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jalan Teuku Cik Ditiro 1 No. 11 A, B, C, Gedung Graha Anam, 2nd Floor, Kelurahan Gondangdia, Kecamatan Menteng, Jakarta Pusat, Jakarta, IDN, 10350

Website

https://www.diagnos.co.id

PT Diagnos Laboratorium Utama Tbk provides laboratory services that include health support service activities that are managed by both the government and the private sector, such as health laboratories. The business products and services include Clinical Pathology Laboratory, Anatomy Pathology Laboratory, Genomic Laboratory, Homecare Health Services, and Corporate Health Service.